Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 251 papers

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis

Torres S, Ortiz C, Bachtler N, Gu W, Grünewald LD, Kraus N, Schierwagen R, Hieber C, Meier C, Tyc O, Joseph Brol M, Uschner FE, Nijmeijer B, Welsch C, Berres ML, Garcia-Ruiz C, Fernandez-Checa JC, Trautwein C, Vogl TJ, Zeuzem S, Trebicka J, Klein S.

Hepatology 2023, 77(4): 1228–1240

DOI: 10.1002/hep.32746

Randomized-controlled trial of the DIALIVE liver dialysis device vs. standard of care in patients with acute-on-chronic liver failure

Agarwal B, Cañizares RB, Saliba F, Ballester MP, Tomescu DR, Martin D, Stadlbauer V, Wright G, Sheikh M, Morgan C, Alzola C, Lavin P, Green D, Kumar R, Sacleux SC, Schilcher G, Koball S, Tudor A, Minten J, Domenech G, Aragones JJ, Oettl K, Paar M, Waterstradt K, Bode-Boger SM, Ibáñez-Samaniego L, Gander A, Stange J, Lamprecht G, Sanchez M, Mookerjee RP, Davenport A, Davies N, Pavesi M, Andreola F, Albillos A, Cordingley J, Schmidt H, Carbonell-Asins JA, Arroyo V, Fernandez J, Mitzner S, Jalan R.

J Hepatol 2023, S0168-8278(23)00188-5

DOI: 10.1016/j.jhep.2023.03.013

Essential role for albumin in preserving liver cells from TNFα-induced mitochondrial injury

Duran-Güell M, Garrabou G, Flores-Costa R, Casulleras M, López-Vicario C, Zhang IW, Cantó-Santos J, Contreras BJ, Sánchez-Rodríguez MB, Romero-Grimaldo B, Horrillo R, Costa M, Arroyo V, Clària J.

FASEB J 2023, 37(3): e22817

DOI: 10.1096/fj.202201526R

Attitudes toward liver transplantation for ACLF-3 determine equity of access

Artzner T, Belli LS, Faitot F, Jalan R.

J Hepatol 2023, 78(3):e93-e95

DOI: 10.1016/j.jhep.2022.10.029

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: The metabolomic prognostic models (CLIF-C MET)

Weiss E, de la Peña-Ramirez C, Aguilar F, Lozano JJ, Sánchez-Garrido C, Sierra P, Martin PI, Diaz JM, Fenaille F, Castelli FA, Gustot T, Laleman W, Albillos A, Alessandria C, Domenicali M, Caraceni P, Piano S, Saliba F, Zeuzem S, Gerbes AL, Wendon JA, Jansen C, Gu W, Papp M, Mookerjee R, Gambino CG, Jiménez C, Giovo I, Zaccherini G, Merli M, Putignano A, Uschner FE, Berg T, Bruns T, Trautwein C, Zipprich A, Bañares R, Presa J, Genesca J, Vargas V, Fernández J, Bernardi M, Angeli P, Jalan R, Claria J, Junot C, Moreau R, Trebicka J, Arroyo V.

 Gut 2023, 72(8): 1581–1591

DOI: 10.1136/gutjnl-2022-328708

Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis

Reiniš J, Petrenko O, Simbrunner B, Hofer BS, Schepis F, Scoppettuolo M, Saltini D, Indulti F, Guasconi T, Albillos A, Téllez L, Villanueva C, Brujats A, Garcia-Pagan JC, Perez-Campuzano V, Hernández-Gea V, Rautou PE, Moga L, Vanwolleghem T, Kwanten WJ, Francque S, Trebicka J, Gu W, Ferstl PG, Gluud LL, Bendtsen F, Møller S, Kubicek S, Mandorfer M, Reiberger T.

J Hepatol 2023, 78(2): 390–400

DOI: 10.1016/j.jhep.2022.09.012

Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acute decompensation of cirrhosis

Li B, Hong C, Fan Z, Cai S, He Q, Lan X, Lai Q, Ji Y, Luo W, Li J, Cheng X, Liu M, Gu Y, Lu G, Li S, Wang Y, Weng X, Niu X, Liu Q, Jalan R, Chen J.

J Hepatol 2023, 78(2): 322–332

DOI: 10.1016/j.jhep.2022.10.008

Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis

Zanetto A, Pelizzaro F, Campello E, Bulato C, Balcar L, Gu W, Gavasso S, Saggiorato G, Zeuzem S, Russo FP, Mandorfer M, Reiberger T, Trebicka J, Burra P, Simioni P, Senzolo M.

J Hepatol 2023, 78(2): 301–311

DOI: 10.1016/j.jhep.2022.09.005

Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS

Dold L, Nielsen MJ, Praktiknjo M, Schwarze-Zander C, Boesecke C, Wasmuth JC, Bischoff J, Rockstroh JK, Karsdal MA, Spengler U, Trebicka J, Strassburg CP, Leeming DJ, Langhans B.

Hepatology 2023, 77(2): 466–475

DOI: 10.1002/hep.32676

Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV

Dold L, Nielsen MJ, Praktiknjo M, Schwarze-Zander C, Boesecke C, Wasmuth JC, Bischoff J, Rockstroh JK, Karsdal MA, Spengler U, Trebicka J, Strassburg CP, Leeming DJ, Langhans B.

BMC Infect Dis 2023, 23(1): 52

DOI: 10.1186/s12879-023-08000-w

Registered office

European Foundation for the Study of
Chronic Liver Failure
Travessera de Gràcia 11, 7th floor
08021 Barcelona, Spain

Legal

Contact us

T +34 93 227 14 00
E efclif@efclif.com

© European Foundation for the Study of Chronic Liver Failure 2024